Development of an evidence-based model of rapid testing, counseling and referral patients with HIV, HVC and other STDs in Mexican addiction treatment centers
##plugins.themes.bootstrap3.article.main##
Resumen
Objetivo. Describir el proceso de desarrollo del modelo OPB-APR para la detección, orientación y referencia de personas con VIH y otras ITS en centros de tratamiento de adicciones.
Método. El procedimiento se dividió en tres fases: 1. Revisión de literatura para identificar conceptos básicos sobre el VIH y otras ITS, consumo de sustancias, conductas sexuales de riesgo, pruebas rápidas, y orientación psicológica especializada; 2. Estudio de factibilidad en el que se entrenó a profesionales de la saludpara implementar el modelo OPB-APR; 3. Integración de la versión final.
Resultados. Se obtuvo la versión final del modelo OPB-APR el cual describe procedimientos estandarizados para la detección, orientación y referencia a servicios de salud.
Discusión y conclusión. El modelo OPB-APR pretende fortalecer al sistema público de salud al incrementar la cobertura de servicios para la detección del VIH, VHC y otras ITS. Lo anterior mediante la implementación de procedimientos estandarizados entre los profesionales de la salud especializados y no especializados de centros para la atención de adicciones.
Referencias
Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet, 376(9738), 367-387. doi: 10.1016/S0140-6736(10)60829-X
Benhamou, Y., Bochet, M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., ... Poynard, T. (1999). Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology, 30(4), 1054-1058. doi: 10.1002/hep.510300409
Centers for Disease Control and Prevention. (2019). Syphilis Surveillance Supplement 2013–2017. Atlanta, Georgia: U.S. Department of Health and Human Services. Retrieved from: https://www.cdc.gov/std/stats17/syphilis2017/Syphilis-Surveillance-Supplement-2013-2017.pdf
Centro de Investigación en Enfermedades Infecciosas [CIENI]. (2011). 30 años del VIH-SIDA: Perspectivas desde México. Mexico: CIENI. Retrieved from: http://www.censida.salud.gob.mx/descargas/biblioteca/documentos/30aniosdelvihsida.pdf
Centro Nacional para la Prevención y Control del VIH y el sida [CENSIDA]. (2019). Guías y Manuales. Mexico. Retrieved from: https://www.gob.mx/censida/articulos/guias-y-manuales-censida?idiom=es
Chander, G., Himelhoch, S., & Moore, R. D. (2006). Substance abuse and psychiatric disorders in HIV-positive patients. Drugs, 66(6), 769-789. doi: 10.2165/00003495-200666060-00004
Fundación Mexicana para la Salud Hepática. (2011). La hepatitis C como un problema de salud pública en México. Salud Pública de México, 53(Supl 1), S61-S67. ISSN: 0036-3634
Grebely, J., & Tyndall, M. W. (2011). Management of HCV and HIV infections among people who inject drugs. Current Opinion in HIV and AIDS, 6(6), 501-507. doi: 10.1097/COH.0b013e32834bcb36
Johnson, M., Samarina, A., Xi, H., Valdez Ramalho Madruga, J., Hocqueloux, L., Loutfy, M., ... Martinez, M. (2015). Barriers to access to care reported by women living with HIV across 27 countries. AIDS Care, 27(10), 1220-1230. doi: 10.1080/09540121.2015.1046416
Klinkenberg, W. D., Sacks, S., & HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group. (2004). Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care, 16(Supp1), S22-S42. doi: 10.1080/09540120412331315303
Magis-Rodríguez, C. L., Villafuerte-García, A., Cruz-Flores, R. A., & Uribe-Zuniga, P. (2015). Delayed initiation of antiretroviral therapy in Mexico. Salud Publica de Mexico, 57(Suppl 2), s127-s134. PMID:26545128
Marcus, U., Bremer, V., Hamouda, O., Kramer, M. H., Freiwald, M., Jessen, H., ... Zimmer, Y. (2006). Understanding recent increases in the incidence of sexually transmitted infections in men having sex with men: Changes in risk behavior from risk avoidance to risk reduction. Sexually Transmitted Diseases, 33(1), 11-17. doi: 10.1097/01.olq.0000187224.10428.31
Marín-Navarrete, R., Magis-Rodríguez, C., & Strathdee, S. A. (2017). Sexually transmitted infections and substance use disorders: evidence and challenges in Mexico. Salud Mental, 40(1), 1-4. doi: 10.17711/SM.0185-3325.2017.001
Marín-Navarrete, R., Magis-Rodríguez, C., Medina-Mora, M. E., & Uribe-Zuñiga, P. E. (2019). Guía para la detección, orientación y referencia del VIH y otras ITS en centros para la atención de adicciones. Mexico: INPRFM, CENSIDA.
Marín-Navarrete, R., Medina-Mora, M. E., & Tena-Suck, A. (2014). Breve panorama del tratamiento de las adicciones en México. A. Tena-Suck y R. Marín N. (Eds.). Temas Selectos en Orientación Psicológica VIII: Orientación Psicológica y Adicciones, (1-7).
Marín-Navarrete, R., Medina-Mora, M. E., Pérez-López, A., & Horigian, V. E. (2018). Development and evaluation of addiction treatment programs in Latin America. Current Opinion in Psychiatry, 31(4), 306-314. doi: 10.1097/YCO.0000000000000434
Marín-Navarrete, R., Villalobos-Gallegos, L., Medina-Mora, M. E., & Magis-Rodríguez, C. (2019). Rapid testing and counseling for HIV/STIs in Mexican community-based residential care facilities for substance use disorders: A prospective study protocol. Journal of Substance Use, 24(3), 329-335. doi: 10.1080/14659891.2019.1572801
Moyer, V. A. (2013). Screening for hepatitis C virus infection in adults: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 159(5), 349-357. doi: 10.7326/0003-4819-159-5-201309030-00672
Posse, M., Meheus, F., Van Asten, H., Van Der Ven, A., & Baltussen, R. (2008). Barriers to access to antiretroviral treatment in developing countries: a review. Tropical Medicine & International Health, 13(7), 904-913. doi: 10.1111/j.1365-3156.2008.02091.x
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., ... Gray, R. H. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. New England Journal of Medicine, 342(13), 921-929. doi: 10.1056/NEJM200003303421303
Rabkin, J. G., McElhiney, M. C., & Ferrando, S. J. (2004). Mood and substance use disorders in older adults with HIV/AIDS: methodological issues and preliminary evidence. AIDS, 18(Suppl 1), S43-S48. PMID: 15075497
Rawat, A., Uebel, K., Moore, D., Cingl, L., & Yassi, A. (2018). Patient responses on quality of care and satisfaction with staff after integrated HIV care in South African Primary Health Care Clinics. Journal of the Association of Nurses in AIDS Care, 29(5), 698-711. doi: 10.1016/j.jana.2018.04.014
Rhodes, T., Platt, L., Maximova, S., Koshkina, E., Latishevskaya, N., Hickman, M. ... Parry, J. V. (2006). Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction, 101(2), 252-266. doi: 10.1111/j.1360-0443.2006.01317.x
Sánchez-Domínguez, R., Villalobos-Gallegos, L., Félix-Romero, V., Morales-Chainé, S., & Marín-Navarrete, R. (2017). Effect of substance use on condom use in the Theory of Planned Behavior: Analysis of differential item functioning. Salud Mental, 40(1), 5-14. doi: 10.17711/SM.0185-3325.2017.002
Scheinmann, R., Hagan, H., Lelutiu-Weinberger, C., Stern, R., Des Jarlais, D. C., Flom, P. L., & Strauss, S. (2007). Non-injection drug use and hepatitis C virus: A systematic review. Drug and Alcohol Dependence, 89(1), 1-12. doi: 10.1016/j.drugalcdep.2006.11.014
Schneider, H., Blaauw, D., Gilson, L., Chabikuli, N., & Goudge, J. (2006). Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges. Reproductive Health Matters, 14(27), 12-23. doi: 10.1016/S0968-8080(06)27232-X
Singh, K. P., Crane, M., Audsley, J., Avihingsanon, A., Sasadeusz, J., & Lewin, S. R. (2017). HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS, 31(15), 2035-2052. doi: 10.1097/QAD.0000000000001574
Strathdee, S. A., Philbin, M. M., Semple, S. J., Pu. M., Orozovich, P., Martinez, G. … Patterson, T. L. (2008). Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug and Alcohol Dependence, 92(1-3), 132-140. doi: 10.1016/j.drugalcdep.2007.07.001
Sulkowski, M. S., Thomas, D. L., Chaisson, R. E., & Moore, R. D. (2000). Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA, 283(1), 74-80. doi: 10.1001/jama.283.1.74
Szerman, N., Martínez-Raga, J., Baler, R., Roncero, C., Vega, P., Basurte, I., ... Spinnato, G. (2017). Joint statement on dual disorders: Addiction and other mental disorders. Salud mental, 40(6), 245-247. doi: 10.17711/SM.0185-3325.2017.031
The Joint United Nations Programme on HIV/AIDS [UNAIDS]. (2014). 90-90-90: A transformative agenda to leave no one behind. In: Launch of Vietnam’s 90-90-90 initiative (pp. 2-8).
The Joint United Nations Programme on HIV/AIDS [UNAIDS]. (2016). Do no harm: Health, human rights and people who use drugs. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS.
Thio, C. L., Seaberg, E. C., Skolasky, R. Jr., Phair, J., Visscher, B., Muñoz, A., & Thomas, D. L. (2002). HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). The Lancet, 360(9349), 1921-1926. doi: 10.1016/s0140-6736(02)11913-1
Treloar, C., Newland, J., Rance, J., & Hopwood, M. (2010). Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals. Journal of Viral Hepatitis, 17(12), 839-844. doi: 10.1111/j.1365-2893.2009.01250.x
Villalobos-Gallegos, L., Medina-Mora, M. E., Benjet, C., Ruiz-Velasco, S., Magis-Rodriguez, C., & Marín-Navarrete, R. (2019). Multidimensional patterns of sexual risk behavior and psychiatric disorders in men with substance use disorders. Archives of Sexual Behavior, 48(2), 599-607. doi: 10.1007/s10508-018-1227-2
Wong, W., Chaw, J. K., Kent, C. K., & Klausner, J. D. (2005). Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002–2003. Sexually Transmitted Diseases, 32(7), 458-463. doi: 10.1097/01.olq.0000168280.34424.58
